Kenneth D. Eichenbaum net worth and biography

Kenneth Eichenbaum Biography and Net Worth

Director of InfuSystem

Kenneth D. Eichenbaum, MD, MSE has been a member of the Company's Board of Directors since May 16, 2024. Dr. Eichenbaum is a board-certified anesthesiologist with extensive clinical and healthcare technology experience. He specializes in the intersection of clinical care, systems engineering and healthcare investment. Dr. Eichenbaum has maintained clinical practice affiliations with Corewell Health William Beaumont University Hospital and Trinity Health Oakland Hospital since 2017 and 2021, respectively. He is a Clinical Associate Professor at Wayne State School of Medicine and a Clinical Assistant Professor at Oakland University William Beaumont School of Medicine. Dr. Eichenbaum completed a fellowship in Cardiothoracic Anesthesia at Stanford University Medical Center and holds a medical degree from the Icahn School of Medicine at Mount Sinai in New York. He also holds a Master of Science in Data Network Engineering, a Bachelor of Science in Materials Science Engineering from the University of Pennsylvania and a Bachelor's degree from The Wharton School with a concentration in Finance. Dr. Eichenbaum currently serves on the Board of Directors of Femasys Inc. (Nasdaq: FEMY), a leading biomedical innovator with a portfolio of therapeutic and diagnostic products designed to improve patient care, accessibility and health economics for women's health needs worldwide. He also serves on the Finance and Contracting Committee of Arvon CIN, an accountable care organization that partners more than 4,500 Physicians with Corwell Health, Michigan's largest healthcare System.

Dr. Eichenbaum brings to the board a blend of clinical expertise, investment experience and healthcare technology insight cultivated over more than two decades, including advising and evaluating medical device, healthcare services and biotech companies.

What is Kenneth D. Eichenbaum's net worth?: The estimated net worth of Kenneth D. Eichenbaum is at least $53.40 thousand as of May 28th, 2025. Dr. Eichenbaum owns 6,000 shares of InfuSystem stock worth more than $53,400 as of July 23rd. This net worth evaluation does not reflect any other assets that Dr. Eichenbaum may own. Learn More about Kenneth D. Eichenbaum's net worth.
How do I contact Kenneth D. Eichenbaum?: The corporate mailing address for Dr. Eichenbaum and other InfuSystem executives is 3851 West Hamlin Road, Rochester Hills, MI 48309, United States. InfuSystem can also be reached via phone at (248) 291-1210. Learn More on Kenneth D. Eichenbaum's contact information.
Has Kenneth D. Eichenbaum been buying or selling shares of InfuSystem?: Kenneth D. Eichenbaum has not been actively trading shares of InfuSystem within the last three months. Most recently, on Wednesday, May 28th, Kenneth D. Eichenbaum bought 2,000 shares of InfuSystem stock. The stock was acquired at an average cost of $5.18 per share, with a total value of $10,360.00. Following the completion of the transaction, the director now directly owns 6,000 shares of the company's stock, valued at $31,080. Learn More on Kenneth D. Eichenbaum's trading history.
Who are InfuSystem's active insiders?: InfuSystem's insider roster includes Kenneth Eichenbaum (Director), Carrie Lachance (President and Chief Executive Officer), and Barry Steele (Executive Vice President and Chief Financial Officer). Learn More on InfuSystem's active insiders.
Are insiders buying or selling shares of InfuSystem?: During the last year, InfuSystem insiders bought shares 5 times. They purchased a total of 17,064 shares worth more than $150,396.24. During the last year, insiders at the sold shares 1 times. They sold a total of 5,752 shares worth more than $55,621.84. The most recent insider tranaction occured on May, 11th when CEO Carrie Lachance bought 1,000 shares worth more than $8,460.00. Insiders at InfuSystem own 10.8% of the company. Learn More about insider trades at InfuSystem.
Information on this page was last updated on 5/11/2026.

Kenneth D. Eichenbaum Insider Trading History at InfuSystem

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/28/2025	Buy	2,000	$5.18	$10,360.00	6,000
9/23/2024	Buy	4,000	$5.89	$23,560.00	4,000

Kenneth D. Eichenbaum Buying and Selling Activity at InfuSystem

InfuSystem Company Overview

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Today's Range

Now: $8.91

$8.86

$9.12

50 Day Range

MA: $9.31

$8.61

$10.16

2 Week Range

Now: $8.91

$5.43

$11.04

Volume

113,554 shs

Average Volume

168,649 shs

Market Capitalization

$179.72 million

P/E Ratio

148.44

Dividend Yield

N/A

Beta

1.4